Please login to the form below

Not currently logged in
Email:
Password:

NHS news in brief

Our weekly round-up of NHS and healthcare stories

New inquiry into NHS IT upgrade
The National Audit Office (NAO) is to launch another inquiry into the controversial ?6.8bn NHS IT upgrade project. The programme, run by a governmental agency called Connecting for Health, aims to link 30,000 GPs with 300 hospitals in England. The NAO issued a report in June, criticising delays in the project. It said the exact remit and timescale of the new investigation had not been decided yet. ìWhen we published the report, we said we may revisit it and that is what we are doing,î said an NAO spokesman.

Pyschiatrists call for Alzheimer's drug rethink
In a study, psychiatrists have called for a re-examination of the way resources are allocated on the NHS for dementia care, and in particular the use of cholinesterase inhibitors. In 2001, the National Institute for Health and Clinical Excellence (NICE) recommended that licensed cholinesterase inhibitors donepezil, rivastigmine and galantamine be made available on the NHS for the treatment of mild-to-moderate Alzheimer's disease. However, the research has revealed ìquite consistently that these medicines have modest beneficial effects compared with placebo,î according to the report's lead author, Anthony Pelosi, consultant psychiatrist at Hairmyres Hospital in Scotland.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics